Read the opinions and background on this issue from the scientific community, and review the testimony of industry experts on ensuring patient safety in the process of creating follow-on biologics.
There is information from a patient advocacy group, the European commission, and Avalere Health, a healthcare advisory firm. Testimony from Jay P. Siegel, and other prominent experts.